Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with RCUS: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
RCUS
Arcus Biosciences, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
RCUS
Arcus Biosciences, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LLY, solid
RCUS, dashed
LLY
ELI Lilly & Co
Change
1,371.32
· pre 1,347.00
· delayed
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
RCUS
Arcus Biosciences, Inc.
Change
17.69
· pre 18.48
· delayed
Pre-market
Nov 6 '26
delayed
Mkt cap
$2.5B
Revenue
$9M
Q3 FY26
Revenue
$247M
FY25
vs
Compare
Pre-market
Nov 6 '26
delayed
LLY
ELI Lilly & Co
vs
RCUS
Arcus Biosciences, Inc.
1,371.32
pre 1,347.00
delayed
Price
17.69
pre 18.48
delayed
$1.2T
Mkt cap
$2.5B
Q3 FY26
$24.4B
Revenue
$9M
Q3 FY26
FY25
$65.2B
Revenue
$247M
FY25
Change
Change
LLY
1,371.32
vs
RCUS
17.69
Pre-market
Nov 6 '26
delayed